Imodium

Loperamide Hydrochloride, the active ingredient in Imodium, is a peripherally acting opioid agonist presented as an oral formulation for oral use. It reduces intestinal motility and is used to manage acute and chronic diarrhea in adults and children when appropriate. GNH USA supplies Imodium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imodium is an antidiarrheal medication that acts on the gastrointestinal tract to control excess stool output. - Acute nonspecific diarrhea: decreases stool frequency and liquidity in sudden‑onset diarrhea. - Chronic diarrhea: helps maintain regularity in long‑term diarrheal conditions. - Irritable bowel syndrome with diarrhea (IBS‑D): reduces bowel urgency and improves stool consistency.

Common Side Effects: - Constipation: reduced bowel movements or hard stools. - Abdominal cramps: mild to moderate discomfort. - Nausea: occasional feeling of queasiness. - Dizziness: transient light‑headedness. - Dry mouth: reduced salivation. - Flatulence: increased gas production.

Serious or Rare Side Effects: - Severe constipation leading to bowel obstruction. - Toxic megacolon in predisposed individuals. - Cardiac arrhythmias: QT prolongation at high doses. - Allergic reactions: rash, itching, swelling. - Central nervous system depression: rare at supratherapeutic levels.

Before using Imodium, consider the following precautions: - Underlying infection: avoid if diarrhea is caused by bacterial or parasitic infection. - Severe liver disease: use with caution as metabolism may be impaired. - Pediatric use: follow pediatric dosing guidelines and avoid in very young children. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Drug interactions: review concomitant medications for potential interactions. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Imodium may interact with several medications. Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase loperamide plasma levels. - P-glycoprotein inhibitors (e.g., quinidine, verapamil): can raise systemic exposure. - CNS depressants (e.g., opioids, benzodiazepines): risk of additive sedation. Moderate Interactions (Monitor Closely): - Anticholinergic agents: may exacerbate constipation. - Antidiarrheal agents (e.g., bismuth subsalicylate): overlapping effects. - Certain antibiotics (e.g., rifampin): may reduce efficacy.